Pages that link to "Q42939897"

The following pages link to Human immunodeficiency virus 1. Predominance of a group-specific neutralizing epitope that persists despite genetic variation (Q42939897):

Displaying 30 items.

• Epitope mapping: the first step in developing epitope-based vaccines (Q33285288) (← links)
• Characterization of simian-human immunodeficiency virus envelope glycoprotein epitopes recognized by neutralizing antibodies from infected monkeys (Q33785114) (← links)
• Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers (Q33836042) (← links)
• Tissue infiltration in a CD8 lymphocytosis syndrome associated with human immunodeficiency virus-1 infection has the phenotypic appearance of an antigenically driven response (Q33899991) (← links)
• Assessment of HIV vaccine development: past, present, and future (Q34050712) (← links)
• V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Tria (Q34171212) (← links)
• Assembly, structure, and antigenic properties of virus-like particles rich in HIV-1 envelope gp120. (Q35700066) (← links)
• Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120. (Q36635175) (← links)
• Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody. (Q36649240) (← links)
• Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding (Q36649958) (← links)
• Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions (Q36650881) (← links)
• Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons (Q36655953) (← links)
• Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120 (Q36690500) (← links)
• Peptide component vaccine engineering: targeting the AIDS virus (Q36708999) (← links)
• A predominant group-specific neutralizing epitope of human immunodeficiency virus type 1 maps to residues 342 to 511 of the envelope glycoprotein gp120. (Q36821056) (← links)
• HIV types and testing (Q36845332) (← links)
• Neutralizing antibodies in cats infected with feline immunodeficiency virus (Q37128778) (← links)
• Targeted deletion in the beta20-beta21 loop of HIV envelope glycoprotein gp120 exposes the CD4 binding site for antibody binding (Q37179763) (← links)
• Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans (Q37548597) (← links)
• Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody (Q37603996) (← links)
• Immunology of HIV infection (Q37615905) (← links)
• Structure and Function in Recombinant HIV-1 gp120 and Speculation about the Disulfide Bonding in the gp120 Homologs of HIV-2 and SIV (Q38337537) (← links)
• Evidence for similar recognition of the conserved neutralization epitopes of human immunodeficiency virus type 1 envelope gp120 in humans and macaques (Q39604142) (← links)
• Molecular biology and pathogenesis of animal lentivirus infections. (Q39820667) (← links)
• Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region (Q40061779) (← links)
• Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody (Q40062738) (← links)
• Envelope Sequence Variation, Neutralizing Antibodies, and Primate Lentivirus Persistence (Q40393218) (← links)
• Global analysis of lymphocyte gene expression: perturbation of H-9 cells by infection with distinct isolates of human immunodeficiency virus--an exposition by multivariate analysis of a host-parasite interface. (Q41165707) (← links)
• Neutralization of Divergent HIV-1 Isolates by Conformation-Dependent Human Antibodies to Gp120 (Q42129803) (← links)
• Genetic characterization of low-pathogenic avian influenza viruses isolated on the Izumi plain in Japan: possible association of dynamic movements of wild birds with AIV evolution. (Q47558296) (← links)